Anti‐Thymocyte Globulin as a Therapy for Chronic Lung Allograft Dysfunction: A Single‐Center Experience

Documenti analoghi

• Association of Community Distress With Lung Transplant Waitlist Acceptance
  di: William M. Brandon, et al.
  Pubblicazione: (2025)
• Long‐Term Outcomes Among Lung Transplant Recipients With High‐Risk Cytomegalovirus Mismatch Managed With a Multimodality Regimen
  di: Natasha Banga, et al.
  Pubblicazione: (2025)
• Kidney Allograft Outcomes of Dual‐Organ Heart Kidney Transplant Recipients Following Donation After Circulatory Determination of Death
  di: Ananya Gorrai, et al.
  Pubblicazione: (2026)
• Absolute CD3 + T‐Cell Counts After Anti‐Thymocyte Globulin: Impact on Graft and Infectious Outcomes in Pediatric Kidney Recipients
  di: Travis Churilla, et al.
  Pubblicazione: (2025)
• Low Absolute Lymphocyte Count Associated With Anti‐Thymocyte Globulin Induction May Be a Predictor of Early Cytomegalovirus Infection in Pediatric Heart Transplantation
  di: Allyson Chan, et al.
  Pubblicazione: (2025)